KARLIE CASON: Open Payments
NPI 1427294867 · CHANDLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,498 in 57 payments from 10 companies in 2025. Trend: 2023 $806 · 2024 $922 · 2025 $1,498
Food & beverage: $1,298Education: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $331 |
| GENZYME CORPORATION | 15 | $325 |
| UCB, Inc. | 8 | $253 |
| Janssen Biotech, Inc. | 7 | $203 |
| Galderma Laboratories, L.P. | 5 | $163 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 4 | $67 |
| Lilly USA, LLC | 1 | $19 |
| Incyte Corporation | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: DUPIXENT, SKYRIZI, Bimzelx, TREMFYA, NEMLUVIO, RINVOQ, EBGLYSS, OPZELURA.
Industry payments across TX — which companies pay providers there.
